GlassScriptPhysician profile
Lance M Villeneuve
NPI 1114418431
$3,257.76
in general payments reported to CMS, 2019-2025
8 companies · $1,405 in 2025
The $1,405 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $217 · 2023: $1,389 · 2024: $246 · 2025: $1,405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,866 · Food and Beverage: $931 · Education: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,865.56 |
| Food and Beverage | $930.55 |
| Education | $244.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Icotec Medical INC. | $1,100.13 | 2023 | Icotec Blackarmor Spine System |
| Synthes Gmbh | $1,036.91 | 2025 | |
| Medtronic, INC. | $377.52 | 2023-2025 | Mazor X System, Cd Horizon Spinal System, Accurian |
| Globus Medical, INC. | $310.78 | 2021-2025 | Excelsius3d Imaging System, Excelsiusgps Robotic Navigation System, Excelsius Gps |
| Integra Lifesciences Corporation | $152.08 | 2025 | Duraseal Exact Spinal Sealant System, Codman Certas, Cusa Clarity |
| Penumbra, INC. | $148.00 | 2021 | |
| Irras USA, INC. | $117.67 | 2024 | |
| Lightbody Medical Technologies INC | $14.67 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Villeneuve listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.